Back to Agenda
T1S5: Strategic Role of RWE in Evidence Planning
Session Chair(s)
Shruti MP, MSC
Director-Real World Data Solutions, Parexel International, India
As the demand for robust, patient-centered data grows, RWE is becoming a critical component in shaping regulatory, market access, and clinical decisions. The sessions will cover best practices, evolving methodologies, and the future landscape of RWE in driving more informed and impactful evidence strategies.
Speaker(s)
Amrita Ostawal
Managing Director, Arete Access, India
Role of RWE In Evidence-Based Medicine
Sriram Govindan
Associate Director-Publications, Global Scientific Communications, Eli Lilly Services India Private Limited, India
Integrated Evidence Generation Plans- Bridging Clinical Trials, RWE and Market Access
Ambika Subramanian
Head Medical Writing, Life Sciences Consulting, NTT Data, India
With the Additional Presence of
Alben Sigamani
Director & Founding Professor, Carmel Research Consultancy Pvt. Ltd., India
With the Additional Presence of
Have an account?